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Since the discovery of the Marburg and Ebola species of filovirus, seemingly random, sporadic
fatal outbreaks of disease in humans and nonhuman primates have given impetus to
identification of host tropisms and potential reservoirs. Domestic swine in the Philippines,
experiencing unusually severe outbreaks of porcine reproductive and respiratory disease syndrome,
have now been discovered to host Reston ebolavirus (REBOV). Although REBOV is the only member
of Filoviridae that has not been associated with disease in humans, its emergence in the human
food chain is of concern. REBOV isolates were found to be more divergent from each other than
from the original virus isolated in 1989, indicating polyphyletic origins and that REBOV has been
circulating since, and possibly before, the initial discovery of REBOV in monkeys.
iloviruses are associated with acute fatal
hemorrhagic diseases of humans and/or
nonhuman primates. The family consists
of two genera: Marburgvirus, which comprises
various strains of the Lake Victoria marburgvirus
(MARV) discovered in 1967; and the antigenically distinct genus Ebolavirus discovered in 1976,
which comprises five species including Sudan
ebolavirus (SEBOV), Zaire ebolavirus (ZEBOV),
Ivory Coast ebolavirus [also known as Cote d’Ivoire
Ebola virus (CIEBOV)], Bundibugyo ebolavirus
(BEBOV), and Reston ebolavirus (REBOV) (1).
REBOV is the only member of the family thus
far not associated with disease in humans (2).
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Since the discovery of filoviruses more than
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interest in delineation of host tropisms, potential
reservoirs for disease transmission, and persistence
in nature (3). These lines of investigation have
recently identified African fruit bats as potential
reservoirs for ZEBOV (4, 5) and MARV (6, 7).
Similar links to bats have been found for emerging
infections in swine and humans involving paramyxoviruses and the severe acute respiratory
syndrome (SARS) coronavirus (8, 9).
Until now, REBOV has only been associated
with disease in nonhuman primates (2, 10). The
virus was originally identified in 1989 in the United
States from a shipment of cynomolgus monkeys
(Macaca fascicularis) from the Philippines. Outbreaks of disease occurred in the United States in
1990 and 1996 and in Italy in 1992, which were
traced back to a single facility in the Philippines
(fig. S1) (11, 12). Here, we report the identification of REBOV infection in domestic swine coinfected with porcine reproductive and respiratory
syndrome virus (PRRSV) that were experiencing
a severe respiratory disease syndrome.
In July 2008, the Philippine Department of
Agriculture requested the assistance of the U.S.
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Fig. 1. Detection of REBOV in swine samples from the Philippines. (A) Composition of the panviral microarray
used to detect REBOV. The microarray feature composition is summarized with reference to the number of
unique features for identification of viral pathogens. FMDV, foot-and-mouth disease virus. (B) Microarray
analysis of Vero cell culture of a swine lymph node from sample group A identified multiple positive features
within the genus of Ebola viruses. These features corresponded primarily to sequences from REBOV with
minimal reactivity toward SEBOV and ZEBOV. MFI, mean fluorescence intensity ( ) Positive Reston ebolavirus
spp. features; ( ) positive Ebolavirus genus features; (◯) non-Ebolavirus features; and (●) negative features.
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Department of Agriculture (USDA), Animal and
Plant Health Inspection Service (APHIS), Foreign
Animal Disease Diagnostic Laboratory (FADDL),
in the diagnostic investigation of recent multiple
outbreaks of a respiratory and abortion disease
syndrome in swine. Clinical signs resembled a

Fig. 2. Immunohistopathology of EBOV and PRRSV. (A)
Lymph node capsule stained
for EBOV antigens. (B) Lymph
node tissue stained for EBOV
antigens. (C) Lung tissue
stained for EBOV antigens.
(D) Lung tissue stained for
PRRSV antigens. (E) Lymph
node germinal center stained
for PRRSV antigens. (A to E)
Immunoalkaline phosphatase
staining, naphthol fast red substrate with light hematoxylin
counterstain. (F) Filovirus particle by negative-staining electron microscopy of the E6 Vero
cell culture of the lymph node.
Scale bar, 100 nm.

highly pathogenic PRRSV infection, also referred
to as “blue ear disease,” which has recently been
spreading through Asia (13–15). Sera and tissue
samples were collected from five groups of swine
at two commercial premises located in Pandi,
Bulacan (sample group A); Manaoag, Pangasinan

A

B

C

D

E

F

A

(sample groups C and E); and two inspection
check points located in Sto. Nino, San Jose City,
Nueva Ecija (sample group B) and Batangas
(sample group D) (fig. S1). The diagnostic investigation at FADDL included diagnostics for
African swine fever and classical swine fever, a
directed investigation for the presence of PRRSV,
and a more general search of other viral agents
potentially contributing to the disease. Selected
tissue samples from each group were tested and
found negative for the presence of African swine
fever, classical swine fever, swine vesicular disease, and foot-and-mouth disease. Consistent with
a respiratory and reproductive disease syndrome,
PRRSV was discovered. Sequence analysis of the
NSP2 gene revealed that it was most homologous
to Chinese PRRSV isolates recently associated
with blue ear disease in Asia. This determination
was based on the presence of two unique deletions in the NSP2 gene of the Philippines PRRSV
isolate that are shared by recent Chinese PRRSV
isolates associated with pathogenic PRRS in Asia
(14, 16). Simultaneously, a lymph node from group
A, cultured in Vero cells, a monkey kidney cell
line nonpermissive for PRRSV, revealed cytopathic
effects indicating the presence of a virus other
than PRRSV.
To resolve such unexplained cases, a panviral
microarray has been developed that used a nearneighbor approach for the identification of taxonomically conserved viral protein microdomains.
This tool consists of tens of thousands of conserved viral genetic signature sequences microscopically arrayed on a slide and is designed to
capture extracted and amplified viral nucleic
acid from a query sample (Fig. 1A). It is similar
in concept and design to previously published
pathogen microarrays, including a panmicrobial
array named the GreeneChip (17, 18) and the
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Fig. 3. Phylogeny of REBOV. (A) Full-length genomic sequences for
Reston08-A, Reston08-C, and Reston08-E were experimentally determined, with the exception of the defined 5′ and 3′ termini, and aligned.
Nucleotide similarity scores and the number of predicted amino acid
changes between swine and monkey REBOV genomes are shown. (B) A
consensus neighbor-joining tree drawn without distance topology illustrates the independent branching of the three 2008 Philippine swine
viruses within the REBOV clade, demonstrating the divergence between each of these viruses. The percent
branching out of 1000 random bootstrap iterations is indicated above each branch.
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ViroChip used to characterize the SARS coronavirus (19).
To identify the unknown virus, the Vero cell
culture was subjected to microarray analysis. Results revealed positive signals for 28 out of 28
distinct array features present in a 3.7-kb span of
the REBOV L gene (Fig. 1B). By contrast, only 3
out of 30 and 2 out of 30 features were positive
for the ZEBOV and SEBOV species, respectively.
No other notable signals other than controls were
positive (Fig. 1B). Because microarray results are
sequence dependent, polymerase chain reaction
(PCR) primers designed from the features themselves were used to PCR amplify and sequence
the viral cDNA captured by the microarray slide.
This sequence analysis confirmed that the captured viral sequences were more than 95% identical to the L gene of all previously sequenced
REBOV isolates. Because REBOV is classified
as a biological safety level 4 select agent, samples
were transferred to the Special Pathogens Branch
at the Centers for Disease Control and Prevention
(CDC) (Atlanta, Georgia), and identification of
REBOV was confirmed by Ebola-specific realtime reverse transcription (RT)–PCR analysis
(table S1), antigen enzyme-linked immunosorbent assay, immunohistochemistry, and virus
isolation in E6 Vero cell culture.
REBOV was only found in sample groups
that also tested positive for PRRSV (table S1).
Histopathological and immunohistochemical examination of lymph nodes from animals infected
with REBOV and PRRSV from groups A and C
showed different patterns of antigen localization
and pathology (Fig. 2, A, B, and E). REBOV
antigens were seen focally in lymphoid and lymph
node capsule tissues with minimal necrosis (Fig. 2,
A and B), whereas PRRSV antigens were seen in
the germinal centers of lymphoid follicles displaying germinal cell hyperplasia and focal necrosis
(Fig. 2E). Immunostaining of lung tissues for
REBOV and PRRSV revealed localization of both
viral antigens in areas displaying mixed inflammatory cells and sloughed necrotic debris in alveolar spaces consistent with interstitial pneumonia
(Fig. 2, C and D). Negative-staining electron microscopy of the E6 Vero cell culture of the lymph
node from the Bulacan site (group A) revealed
filamentous virus particles and partially assembled intermediate particles characteristic of filoviruses (Fig. 2F). Serological studies on 13 swine
sera from groups A, B, and D for the detection of
antibodies to REBOV were negative. In contrast,
antibodies to PRRSV were detected in swine sera
from each of the tested sample groups A, B, and D.
RT-PCR revealed REBOV nucleic acid in
animals from groups C and E, at the Pangasinan
site, and from group A at the Bulacan site (fig. S1
and table S1). Samples from groups B and D did
not test positive for REBOV or PRRSV; however,
PCR revealed porcine circovirus type 2 (PCV-2)
among samples from groups A, B, and D (table S1),
and microarray analysis further revealed Porcine
teschovirus 1 from the SK6 porcine kidney cell
culture of a tonsil from group D.

206

Viral genomes for REBOV identified from
three samples—designated Reston08-A, Reston08C, and Reston08-E—at two geographically distinct
locations were ~18.9 kb in length and confirmed
that the viruses were REBOV species (Fig. 3). The
Reston08 viruses were significantly more divergent from each other (3.93% mean difference in
nucleotide identity) than from the prototypical
reference isolate from 1989 (2.5% mean difference
in nucleotide identity), indicating polyphyletic origins of the REBOV infections in swine at both
locations (Fig. 3A).
The lack of a phylogenetic clade, distinct from
viruses in macaques, for the recent REBOV infections in swine (Fig. 3B) suggests that REBOV
has been circulating since, and possibly before,
the initial discovery of REBOV in monkeys exported from the Philippines in 1989. The isolation
of REBOV from swine represents an extension in
the known host tropism. The interisolate divergence of the three recent swine isolates is greater
than that observed among the monkey isolates
obtained from the single implicated primate export facility (Fig. 3A). Given the broader genetic
diversity and geographic distribution of REBOV
in swine, it is possible that REBOV spilled over
to monkeys and swine from an as yet unidentified
host. Bats have been implicated as reservoirs for
other filoviruses, including ZEBOV and MARV,
and may also represent a candidate reservoir for
REBOV.
Of 141 tested individuals, we identified 6
individuals who worked on pig farms or with
swine products that had positive serum immunoglobulin G (IgG) titers to REBOV, confirming
the potential transmission from pigs to humans.
The remaining 135 individuals tested negative
for IgG titers to REBOV. Given the observed
sequence divergence between the Reston08 viruses, a broader surveillance program is being
planned. REBOV infection in domestic swine
raises concern about the potential for emerging
disease in humans and a wider range of livestock. However, as in previous REBOV incidents, there is no evidence of disease in humans
despite the apparent occurrence of human infections evidenced by seropositive titers of REBOVspecific antibody.
The role of swine as either an incidental host
or an integral part of the virus’s transmission cycle has yet to be determined. Because evidence of
coinfection with PRRSV, an arterivirus, was found
with REBOV, we can speculate about a link between coinfection and disease in swine. This
possibility is of interest in light of the atypical,
highly pathogenic infections in swine by PRRSV
that are currently spreading through Asia (14–16).
Simian hemorrhagic fever virus, a well-known
pathogen of captive primates and also an arterivirus
of previously characterized pathogenicity, was identified in a coinfection of monkeys during the first
detected outbreak of REBOV (20), although later
studies clearly demonstrated the pathogenicity of
REBOV as a single agent in experimentally infected monkeys (21).
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There is concern that its passage through swine
may allow REBOV to diverge and shift its potential for pathogenicity. Moreover, REBOV infections
in swine highlight the need for investigations into
the pathogenesis of REBOV in coinfections or in
immunocompromised hosts. Through domestic
and international interdisciplinary cooperation and
collaboration, it is expected that future epidemiology and pathogenesis studies will shed light on the
potential reservoirs, mode(s) of transmission, mechanisms of pathogenesis, prevalence of REBOV in
nature, and its consequences for agricultural industries and trade.
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Materials and Methods
Panviral microarray design and analysis. A near-neighbor comparison was developed
to identify taxonomically conserved viral peptide microdomains which were then used to
identify 10,768 virus family, genus and/or species specific oligonucleotide features used
to build the panviral microarray. (-) ssRNA virus-specific features included both sense
and antisense sequences. This array was supplemented with various conserved viral
genetic signatures from foreign animal disease diagnostic assays and selected viruses to
achieve 13,181 unique disease pathogen features (Fig. 2A) with an estimated total
theoretical detection coverage for all human, animal, avian and fish viruses with
corresponding sequence in the 2007 NCBI virus nucleotide sequence database. Random
primed sample cDNA was PCR amplified, labeled with biotin using a BioNick™ kit
(Invitrogen) and hybridized to the microarrays at 67 oC for 16 hr in Agilent CGH
microarray hybridization buffer (Agilent Technologies). Microarrays were developed
with 1mM AlexaFluor–546 Streptavidin (Invitrogen) in PBST (2X PBS, 0.1% Tween-20,
1% Bovine Serum Albumin) 30min prior to a final wash and data collection using
Genepix v.6.1 (BioRad).
Characterization of REBOV. Full genome sequence analyses were performed on
REBOV derived from group A (lung tissue and the Vero cell culture of a lymph node,
both from a single animal), group C (a pool of two lymph nodes from different animals),
and group E (the Vero cell culture of a pool of three spleens from different animals).
Histopathology and morphology of PRRSV and REBOV were studied by
immunoalkaline phosphatase staining of formalin-fixed paraffin-embedded tissues and
negative staining electron microscopy of virus from sample group A isolated from E6
Vero cell culture.
Random cDNA amplification for microarray analysis. RNA was extracted from the
Vero cell culture of a lymph node from site A using RNeasy (Qiagen) and treated with
DNA-free DNAse (Ambion). Random cDNA was generated using RT Superscript II
(Invitrogen) and two primers GTTTCCAAGTCACGATCNNNNNNNNN and
GTTTCCAAGTCACGATCTTTTTTTTTTTT. Product was treated with RNase H
(Invitrogen) at 37 oC for 30 minutes followed by treatment with a QiaQuick PCR spin
column (Qiagen). Random cDNA was then 3’ tagged using T4 RNA ligase 1 (New
England Biolabs) and a second tag primer modified by 5’ phosphorylation and a 2',3'dideoxycytidine pAAGGTTCACATTTGTAATG-ddC. Ligation was performed 4 hr at
22 oC in 1x T4 RNA Ligase 1 buffer (New England Biolabs) supplemented with 25%
(w/v) PEG 8000 and 2.5 nM second tag primer (S1). Amplification was then performed
for 36 cycles using tag complementary primers GTTTCCAAGTCACGATC and
CATTACAAATGTGAACCTT. Product was cleaned using QiaQuick PCR spin
columns (Qiagen).

1

PCR methods. Molecular detection of PCV-2 was performed from sample DNA
obtained using a Qiagen DNA mini kit (Qiagen) and PCR using primers PCV-F:
GCTGAACTTTTGAAAGTGAGCGGG and
PCV-R: TCACACAGTCTCAGTAGATCATCCCA with Platinum Taq Supermix
(Invitrogen) and at 94 oC for 12 min followed by 40 cycles of 94 oC for 60 sec, 58 oC for
60 sec, and 72 oC for 60 sec. This yielded a 243 bp PCV specific product that was further
digested with Nco-I (New England Biolabs) to distinguish PCV-2 from PCV-1.
Molecular detection of PRRSV was performed from sample RNA obtained using
an RNeasy Mini kit (Qiagen) and RT-PCR using RT Superscript II followed by the
Advantage 2 PCR kit (Invitrogen) using PRRSV-F: GRACTTCCTCARCTTCTTGC and
PRRSV-R: TCGACGAGCTTAAAGACCAGA primers. Thermocycling conditions
included denaturing at 95 oC for 2 min, followed by 35 cycles of 95 oC for 30 sec, 55 oC
for 30 sec, and 68 oC for 60 sec (Guillermo Risatti, personal communication).
Molecular detection of REBOV L gene was performed from sample RNA
obtained using an RNeasy Mini kit (Qiagen). RT-PCR was performed using RT
Superscript II followed by Platinum Taq Supermix (Invitrogen) with primers REBOVER3-F: ACGAGTATATCCTGTGCACAAATCTCCTTAG and REBOV-ER3-R:
CGAAGGCAGTTCCAATACTGGCAAGTGTTCC primers. PCR conditions were 94
o
C for 12 min followed by 40 cycles of 94 oC for 60 sec, 58 oC for 60 sec, and 72 oC for
60 sec.
Genome amplification of REBOV was performed from extracted RNA and RTPCR was performed as previously described (S2). Denaturing was 94 oC for 2 min
followed by 35 cycles of 94 oC for 15 sec, primer specific annealing temperatures for 30
sec, and 68 oC for 60 sec per 1 kb of expected product size. Primers and annealing
temperatures were as follows: REBOV-1F: CGGACACACAAAAAGAAA and
REBOV-NP-2R-1090: CAAGAAATTAGTCCTCATCAATC, annealing at 48 oC;
REBOV-NP-1F-754: GTATTTGGAAGGTCATGGATTC and REBOV-3080-R:
AGTAAACACCTGCCTACAGA, annealing at 48 oC; REBOV-2841-F:
ACTTACACCGGTCTATCCA and REBOV-5800-R: GAGCATTCAGAATATTGCTT,
annealing at 45 oC; REBOV-5571-F: AGCAGAGGCAACAGACTC and REBOV-8640R: GAACACGAATTTGGGATG, annealing at 47 oC; REBOV-8481-F:
ATCCGGATGATGGAGCAT and REBOV-11921-R: CTGTGCACCTGTTGCCTT,
annealing at 51 oC; REBOV-11741-F: TGATACACCTGTAGCAACA and REBOV13279-R: CATAAAGTTTGGACATTCC, annealing at 43 oC; REBOV-13031-F:
GGATGCAGTCTTTGAACC and REBOV-14760-R: GTACAGGTGTCTCACTGTTG,
annealing at 47 oC, REBOV-14581-F: TGGAAGATGAGATGGTTTG and REBOV18894-R: GGACACACAAAAAGGAAAA, annealing at 47 oC.
Realtime RT-PCR detection of Ebola was performed on sample RNA using
Superscript III One-Step RT-PCR (Invitrogen), 50 uM forward primer
AGTIACMAGTGCMTGTGGGA, 50 uM reverse primer
GGCAGTTCCWATACTGGCAAGT and 10 uM probe 6-FAMCAATCACTCAARACAGCAGCWAGIATGGC-BHQ-1 at 50 oC for 15 min and 95 oC
for 2 min followed by 40 cycles of 95 oC for 15 sec and 56 oC for 45 sec. Results were
recorded using an ABI7500 (Applied Biosystems).
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Genomic sequence analyses. Eight overlapping RT-PCR products spanning the
complete genomes of REBOV from each of the three sample groups (groups A, C and E)
were generated and used for genome sequence determination. Products were treated with
ExoSAP-IT® (USB Corporation), sequenced using the BigDye® Terminator v3.1 Cycle
Sequencing kit (Applied Biosystems), purified with CleanSeq® (Agencourt), and
analyzed on the 96-capilary 3730xl DNA Analyzer (Applied Biosystems). Viral genomic
ends were not experimentally determined. The Reston08-A sequence represents a
composite of sequences obtained from two tissue samples from the same animal that
were independently amplified and sequenced and which differ only in completeness of
the 5’ and 3’ end regions. All shared sequence between these two independent sequence
determinations (18,776 nt) were identical.
Complete genome sequences for filoviruses were aligned in CLUSTAL W using
MEGA v.4.0, and 5’ and 3’ sequence ends were trimmed to obtain a single comparable
data set. Similarity scores were calculated by Maximum Composition Likelihood and
Neighbor Joining methods. DNA Distance method was applied to the tree showing
branch length topology. Consensus trees were derived from 1000 bootstrap iterations.
For PRRSV, RT-PCR products corresponding to NSP2 from each positive sample
group (groups A, C and E) were cloned into E. coli using TOPO-TA (Invitrogen). A
partial NSP2 gene sequence representing the consensus sequence from multiple samples
was submitted to Genbank under the accession number FJ641193. The putative
translation of this consensus sequence was aligned with other Nsp2 PRRSV sequences in
CLUSTAL W using MEGA v.4.0.
Immunohistochemical assays of REBOV and PRRSV. Immunohistochemical (IHC)
assays for detection of EBOV and PRRS viral antigens were performed on formalin-fixed
paraffin-embedded tissue specimens using a modification of a colorimetric indirect
immunoalkaline phosphatase method (UltraVision LPValue Large Volume Detection
System AP Polymer, Thermo Scientific) (S3) . IHC assays included a polyclonal rabbit
anti-EBOV antibody, a hyperimmuned mouse anti-EBOV antibody (both from Special
Pathogens Branch, CDC), and a monoclonal mouse anti-PRRS virus antibody (Rural
Technologies, Inc, Brookings, SD, USA). Both anti-EBOV antibodies cross-react with all
5 species of EBOV. Appropriate positive and negative controls were run in parallel.
Serological Analyses. Analysis of sera was performed for PRRSV, CSFV, and FMDV
using IDEXX HerdChek PRRS 2XR antibody ELISA kit, IDEXX HerdChek CSFV
antibody ELISA kit, and Ceditest FMDV-NS ELISA (Prionics AG), respectively EBOV
IgG detection was performed as previously described by the CDC.
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Supporting Figure

Fig. S1. A topographical map generated using Google Maps showing locations in the
Philippines from where samples were obtained is shown (©2009 Google – Map data
©2009 AND Europa Technologies). Samples were collected in five animal groups
designated groups A-E. The red + represent REBOV positive sites (Lat. 14°49'3.78"N;
Long. 120°53'0.01"E: sample group A) and (Lat. 16° 9'35.23"N; Long. 120° 5'5.03"E:
sample groups C and E) while blue  mark additional sites sampled. The site of the
original isolates of REBOV in monkeys is indicated by a yellow Δ.
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Supporting Table
Table S1. Swine samples and diagnostic PCRs
Group and
Location
Group A
(Bulacan)

Group B
(Neuva Ecija)

Group C*
(Pangasinan)
Group D
(Batangas)
Group E*
(Pangasinan)

Sample
Type

# Tissues
/Pool

PCV-2

Lung

1

+

+

+

Spleen

1

-

-

+

Lymph node

1

-

-

+

Liver

1

-

-

-

Lung

3

+

-

-

Spleen

3

+

-

-

Liver

3

+

-

-

Lung

2

-

+

+

Lymph node

2

-

+

+

Spleen

2

-

-

+

Tonsil

1

+

-

-

Lung

2

-

+

-

Spleen

3

-

+

+

Tonsil

1

-

+

-

PRRSV *REBOV

Swine samples and diagnostic PCRs. Pooled tissue homogenates of similar tissue from
each of five groups were tested by PCR and found to be positive for Porcine Circovirustype 2 (PCV-2) and Porcine Reproductive and Respiratory Syndrome Virus (PRRSV).
Additionally, conventional RT-PCR directed against the L gene of the Reston ebolavirus
and/or Taqman realtime RT-PCR were used to test most tissue samples individually for
the presence of REBOV. * For clarity, REBOV PCR results are presented as + or –
based any given results for 1 or more tissues selected for the pool of tissues. Tissue pool
describes the number of tissues of each type included from individual animals from their
respective group. Symbols represented in the table for PCV-2, PRRS, and REBOV PCR
are: + Positive or - Negative. *Groups C and E were separate groups of animals at the
same premise.
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